Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Like any medicine, these injectables might not work for everyone
It replicates the function of GLP-1, a hormone naturally produced in the body that regulates appetite, metabolism, and blood sugar levels
95% CI [0.991.185]
Diabetologia 2011 , 54 , 965978
Hayes wonders whether people who arent responsive to the drugs might have mutations in their GLP-1 receptorsand whether that could be part of why they gained excess weight in the first place
Regional Segment Analysis of the GLP-1 Receptor Agonist Market North America (U.S., Canada, Mexico) Europe (Germany, France, U.K., Italy, Spain, Rest of Europe) Asia-Pacific (China, Japan, India, Rest of APAC) South America (Brazil and the Rest of South America) The Middle East and Africa (UAE, South Africa, Rest of MEA) North America influenced the market with the largest market share over the forecast period Get more details on this report - Request Free Sample PDF North America is influencing significant market growth during the forecast period due to the region's high prevalence of chronic illnesses such as diabetes and obesity, rising R&D investments for creating novel pharmaceuticals for treating diabetes and obesity, the presence of significant companies, and the well-developed healthcare infrastructure
US$ 29.73
US$ 23.25
US$ 27.77
US$ 24.14
